Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for Faire, Recursion Pharmaceuticals, and 370+ companies. 5-min read every Tuesday.
Faire is the wholesale marketplace connecting 700K+ independent retailers with 100K+ emerging brands — the B2B commerce platform for the indie retail economy. Valued at $12.4B with $1.7B raised, Faire processes billions in annual GMV and is the dominant wholesale marketplace globally. IPO candidate as B2B commerce digitisation continues to disrupt traditional wholesale distribution — a $50B+ global market.
| Industry | E-commerce |
| Stage | Series H |
| IPO Status | Private |
| Valuation | $12.4B |
| Total Funding | $1.7B |
| Headquarters | San Francisco, CA |
AI-powered biotech combining biology, chemistry, and machine learning for drug discovery.
| Industry | Biotechnology |
| Stage | Public |
| IPO Status | Public |
| Valuation | $2.5B |
| Total Funding | $939M |
| Headquarters | Salt Lake City, UT |
Complete funding history, cap table, S-1 analysis, and investor breakdown for any company. Instant PDF download.
Or buy any single company report for $19
Faire is valued at $12.4B. Recursion Pharmaceuticals is valued at $2.5B. Both figures are based on the most recent funding rounds tracked by TechStackIPO.
Faire filed an S-1 in April 2026 and is actively in the IPO pipeline. Recursion Pharmaceuticals is currently already public. Track both companies on TechStackIPO for S-1 filings, roadshow announcements, and IPO date updates.
Faire has raised $1.7B. Recursion Pharmaceuticals has raised $939M.
Faire operates in E-commerce, while Recursion Pharmaceuticals operates in Biotechnology.
Faire is a E-commerce company valued at $12.4B with $1.7B raised. Recursion Pharmaceuticals is a Biotechnology company valued at $2.5B with $939M raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor access options.
Accredited investors can access pre-IPO shares in Faire and Recursion Pharmaceuticals through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.